Identifying Patient Subgroups To Improve Outcome, Resistance And Toxicity In Car T

Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T

VJHemOnc – Video Journal of Hematology & HemOnc

Identifying and managing patients at high risk of developing toxicities following CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Advancements and challenges in CAR-T cell therapy

Tmod cellular logic gate as a solution to on-target, off-tumor toxicity in CAR-T for solid tumors

Updates in CAR T Cell Therapies

National Cancer Institute

Mechanisms and management of short- and long-term CAR-T toxicities

VJHemOnc – Video Journal of Hematology & HemOnc

Managing CAR T-Cell Therapy Toxicity

Understanding Resistance to CAR T Immunotherapy to Develop Better Therapies

Impact of corticosteroids, tocilizumab or filgrastim on the outcomes of CAR-T therapy recipients

VJHemOnc – Video Journal of Hematology & HemOnc

Update on CAR T-Cell Therapy | LRF Webinars

Lymphoma Research Foundation

Strategies to Enhance the Efficacy of CAR T Cells

Yale Cancer Center

Webinar: Engineering strategies for improving adoptive T cell therapy against cancer

Creative Biolabs

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?

Multiple Myeloma Hub

Neurological toxicities associated with chimeric antigen receptor T cell therapy

Understand the resistance mechanims of CAR T cell therapy

Update on CAR T-Cell Therapy | Lymphoma Research Foundation Webinars

Lymphoma Research Foundation

Stratifying patients receiving CAR-T cell therapy with CAR-HEMATOTOX

VJHemOnc – Video Journal of Hematology & HemOnc

Understanding CAR-T Cells - 11/15/18

Side Effects of CAR T Cell Therapy

HealthTree University for Multiple Myeloma

Chimeric Antigen Receptor T-Cell Therapy, From Approval to Practice, Managing Side Effects

OncBrothers: Practice-Changing Cancer Discussions